Skip to main content

Dempze Nancy E

SEC CIK
0001592614
Latest filing
Aug 12, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by Dempze Nancy E, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
6,336
Value
$1.59M
% of portfolio
0.8%
Quarters held
21
Since Q1 2021
Holdings of ABBV by Dempze Nancy E, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20266,336$1.59M0.8%−350−5.2%ReducedHolders
Q1 20266,686$1.45M0.8%−5−0.1%ReducedHolders
Q4 20256,691$1.53M0.8%+1,192+21.7%AddedHolders
Q3 20255,499$1.27M0.7%−356−6.1%ReducedHolders
Q2 20255,855$1.09M0.6%−856−12.8%ReducedHolders
Q1 20256,711$1.41M0.8%−111−1.6%ReducedHolders
Q4 20246,822$1.21M0.7%−70−1.0%ReducedHolders
Q3 20246,892$1.36M0.8%+5,112+287.2%AddedHolders
Q2 20241,780$305.3K0.2%+667+59.9%AddedHolders
Q1 20241,113$202.7K0.2%+1,113NewHolders
Q4 20230$00.0%−1,498−100.0%Sold outHolders
Q3 20231,498$223.3K0.2%−95−6.0%ReducedHolders
Q2 20231,593$214.6K0.2%−150−8.6%ReducedHolders
Q1 20231,743$277.8K0.3%−73−4.0%ReducedHolders
Q4 20221,816$293.5K0.3%00.0%UnchangedHolders
Q3 20221,816$243.0K0.3%−55−2.9%ReducedHolders
Q2 20221,871$286.0K0.3%−315−14.4%ReducedHolders
Q1 20222,186$355.0K0.3%+52+2.4%AddedHolders
Q4 20212,134$289.0K0.2%−1,105−34.1%ReducedHolders
Q3 20213,239$349.0K0.3%−25−0.8%ReducedHolders
Q2 20213,264$368.0K0.3%−1,421−30.3%ReducedHolders
Q1 20214,685$507.0K0.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.